drugset / Trial / NCT02100670

A Multicenter Efficacy Study of a Diclofenac+Menthol Gel in Subjects With Ankle Sprain

NCT02100670

Phase 3 Completed 385 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This Phase III pivotal efficacy study will assess efficacy and onset of pain relief of MFC51123 gel vs. placebo and MFC51123 gel vs. 1% diclofenac gel and 3% menthol gel in participants with an ankle sprain to support topical MFC51123 gel registration.

Timeline

Start
2013-11-01
Primary completion
2015-03-01
Completion
2015-03-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 1 % Topical
Subject Menthol Small molecule 0.09 % Topical
Subject Menthol Small molecule 3 % Topical

Indications

No indication recorded.